Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current DebtOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Payables (2021)

Goldenwell Biotech (GWLL) has disclosed Payables for 1 consecutive years, with $111488.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Payables changed N/A year-over-year to $111488.0, compared with a TTM value of $111488.0 through Dec 2021, changed N/A, and an annual FY2021 reading of $111488.0, changed N/A over the prior year.
  • Payables was $111488.0 for Q4 2021 at Goldenwell Biotech, up from $103125.0 in the prior quarter.
  • Across five years, Payables topped out at $111488.0 in Q4 2021 and bottomed at $103125.0 in Q2 2021.